← Leaderboards
Gregory Robert Moe
Omvax, Inc.
$5,087,569
Attributed
$5,087,569
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2016–24$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,087,569 · 3
By mechanism
R44$3,000,000 · 1
R01$1,787,599 · 1
R41$299,970 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Serum”
- Joseph B. Margolick · Johns Hopkins University$72,041,404
- Monica M Bertagnolli · Strang Cancer Prevention Center$59,344,476
- Leonardo Trasande · New York University School Of Medicine$53,176,255
- Bradley F Boeve · Mayo Clinic Rochester$50,650,130
- Tatiana M. Foroud · Indiana Univ-Purdue Univ At Indianapolis$50,055,104
- Laurence H Baker · University Of Michigan At Ann Arbor$48,684,161
Research focus
SerumVesiclePreventProteinsVaccinesVariantMembranePolysaccharidesConjugate VaccinesComplementEndotoxinsMediatingImmunogenicityInfantBindingAntibodiesAntibody ResponseMutantComplement Factor HBinding ProteinsAntigensAttenuatedBactericideMacaca
Grant awards (9)
Meningococcal and gonococcal vaccine to prevent invasive disease and carriage$373,730
R01 · FY2024 · AI · contact PI
Meningococcal and gonococcal vaccine to prevent invasive disease and carriage$373,730
R01 · FY2023 · AI · contact PI
A next-generation meningococcal serogroup B vaccine with improved effectiveness for all age groups$1,000,000
R44 · FY2022 · AI · contact PI
Meningococcal and gonococcal vaccine to prevent invasive disease and carriage$373,730
R01 · FY2022 · AI · contact PI
A next-generation meningococcal serogroup B vaccine with improved effectiveness for all age groups$1,000,000
R44 · FY2021 · AI · contact PI
Meningococcal and gonococcal vaccine to prevent invasive disease and carriage$373,730
R01 · FY2021 · AI · contact PI
A next-generation meningococcal serogroup B vaccine with improved effectiveness for all age groups$1,000,000
R44 · FY2020 · AI · contact PI
Meningococcal and gonococcal vaccine to prevent invasive disease and carriage$292,679
R01 · FY2020 · AI · contact PI
A universal vaccine for the prevention of meningococcal meningitis in Africa$299,970
R41 · FY2016 · AI · contact PI